⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14814592 | 0.71 | — | — | |
| SCHEMBL20432 | 0.71 | — | — | |
| SCHEMBL5621999 | 0.71 | — | — | |
| SCHEMBL22218 | 0.71 | — | — | |
| SCHEMBL9338826 | 0.71 | — | — | |
| SCHEMBL14814100 | 0.71 | — | — | |
| SCHEMBL5416127 | 0.69 | — | — | |
| SCHEMBL11583721 | 0.69 | — | — | |
| SCHEMBL8681228 | 0.69 | — | — | |
| SCHEMBL10950876 | 0.69 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5591757-A | ADRENERGIC BETA-RECEPTOR BLOCKING AGENTS AND CALCIUM ANTAGONIST | YAMANOUCHI PHARMACEUTICAL CO., LTD. (JP) | 1997-01-07 | — | — | US | disclosed |
| US-5110820-A | Hypotensive agents; cardiovascular disorders | YAMANOUCHI PHARMACEUTICAL CO., LTD. (JP) | 1992-05-05 | — | — | US | disclosed |
| EP-0151006-B1 | DIHYDROPYRIDINE COMPOUNDS, THEIR PRODUCTION, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, AND METHODS OF PRODUCING THESE COMPOSITIONS | YAMANOUCHI PHARMACEUTICAL CO., LTD. (JP) | 1991-08-28 | — | — | EP | disclosed |
| EP-0151006-A2 | Dihydropyridine compounds, their production, pharmaceutical compositions containing them, and methods of producing these compositions | YAMANOUCHI PHARMACEUTICAL CO., LTD. (JP) | 1985-08-07 | — | — | EP | disclosed |